Investors Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,714
Closed -$473K 100
2021
Q4
$473K Sell
1,714
-5
-0.3% -$1.27K 0.22% 119
2021
Q3
$397K Sell
1,719
-4
-0.2% -$987 0.21% 126
2021
Q2
$395K Buy
1,723
+68
+4% +$13.7K 0.21% 122
2021
Q1
$309K Buy
1,655
+138
+9% +$27K 0.18% 135
2020
Q4
$256K Buy
1,517
+83
+6% +$12.4K 0.17% 139
2020
Q3
$212K Sell
1,434
-4
-0.3% -$619 0.16% 138
2020
Q2
$236K Buy
+1,438
New +$221K 0.19% 122

Other funds holding LLY

Investors Financial Group's LLY Position: Q1 2022 in Review

Investors Financial Group sold out of Eli Lilly (LLY) in Q1 2022, closing a stake of 1,714 shares — an estimated $473K sold.

Investors Financial Group first reported a position in LLY in Q2 2020 and held it in 7 quarters. The position peaked at $473K in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

  • Investors Financial Group reported no remaining Eli Lilly position as of Q1 2022 after selling out during the quarter.
  • Investors Financial Group sold 1,714 Eli Lilly shares in Q1 2022, an estimated $473K.
  • Investors Financial Group first reported a position in Eli Lilly in Q2 2020 and held it in 7 quarters.
  • Investors Financial Group's Eli Lilly position peaked at $473K in Q4 2021.
  • 2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Investors Financial Group's 13F filing for Q1 2022.